Clarity Pharmaceuticals Ltd.ASX: CU6

Quarterly Activities/Appendix 4C Cash Flow Report

· Issued by Clarity Pharmaceuticals Ltd. via ASX

Filed with ASX ·

QUARTERLY ACTIVIT Y REPORT SYDNEY, AUSTRALIA 30 SEPTEMBER 2026 HIGHLIGHTS OF THE QUARTER During and since the quarter ending 30 September 2026 Cash Position SECuRE Trial The Company remains well funded with a cash position of The Cohort Expansion (Main Group) of the Phase I/IIa SECuRE $152.9...

View Attachment

6ix is reading this filing.

Clarity Pharmaceuticals Ltd. on 6ix

Earlier from Clarity Pharmaceuticals

All Clarity Pharmaceuticals news releases